Despite the in vitro and in vivo models validating the cellular levels of this mechanism, extensive studies of human Wnt/beta-catenin signaling from the brain tissues of AD patients have been performed [71,73]. The gene discussed is CTNNB1; the disease is Alzheimer disease.